⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31318612 | 0.61 | — | — | |
| SCHEMBL821396 | 0.55 | — | — | |
| SCHEMBL768643 | 0.55 | — | — | |
| SCHEMBL4852319 | 0.50 | — | — | |
| SCHEMBL11432027 | 0.50 | — | — | |
| SCHEMBL2079444 | 0.50 | — | — | |
| SCHEMBL16229961 | 0.50 | — | — | |
| SCHEMBL12461062 | 0.50 | — | — | |
| SCHEMBL12384340 | 0.50 | — | — | |
| SCHEMBL596902 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196267-B1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | APEIRON SYNTHESIS SA (PL) | 2023-11-29 | — | — | EP | disclosed |
| CN-115297931-A | SMARCA degrading agents and uses thereof | 凯麦拉医疗公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-4007041-A1 | BATTERY PACK COMPRISING GAS GENERATION DETECTION DEVICE USING MIE SCATTERING, AND GAS DETECTION METHOD USING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2022-06-01 | — | — | EP | disclosed |
| EP-1945392-B1 | A STEEL PRODUCT WITH A HIGH AUSTENITE GRAIN COARSENING TEMPERATURE, AND METHOD FOR MAKING THE SAME | NUCOR CORP (US) | 2022-01-26 | — | — | EP | disclosed |
| US-11155696-B2 | Preparation and uses of bio-adhesives | NORTH CAROLINA AGRICULTURAL AND TECHNICAL STATE UNIVERSITY (US) | 2021-10-26 | — | — | US | disclosed |
| US-10683263-B2 | Antiviral compounds and methods | BIOTRON LIMITED (AU) | 2020-06-16 | — | — | US | disclosed |
| CN-110144019-A | Refining and purifying method of sugammadex sodium crude product | 合肥博思科创医药科技有限公司 | 2019-08-20 | — | — | CN | disclosed |
| US-20190112454-A1 | PREPARATION AND USES OF BIO-ADHESIVES | NATIONAL SCIENCE FOUNDATION | 2019-04-18 | — | — | US | disclosed |
| US-10025216-B2 | Charging member with electro-conductive elastic layer having exposed bowl-shaped resin particles, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2018-07-17 | — | — | US | disclosed |
| CN-107892727-A | A kind of purification process for the more glucose sodium that relaxes | 合肥博思科创医药科技有限公司 | 2018-04-10 | — | — | CN | disclosed |
| US-20180024460-A1 | CHARGING MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2018-01-25 | — | — | US | disclosed |
| EP-3026494-A2 | ELECTROCONDUCTIVE MEMBER FOR ELECTROPHOTOGRAPHY, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE-FORMING APPARATUS | Canon Kabushiki Kaisha (JP) | 2016-06-01 | — | — | EP | disclosed |
| US-20160024159-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | AMGEN INC. (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2588470-A1 | RIMINOPHENAZINES WITH 2-(HETEROARYL)AMINO SUBSTITUENTS AND THEIR ANTI-MICROBIAL ACTIVITY | Global Alliance For Tb Drug Development (US) | 2013-05-08 | — | — | EP | disclosed |
| US-8361797-B2 | Myeloma cell culture in transferrin-free low iron medium | MEDIMMUNE LIMITED (GB) | 2013-01-29 | — | — | US | disclosed |
| WO-2012003190-A1 | RIMINOPHENAZINES WITH 2-(HETEROARYL)AMINO SUBSTITUENTS AND THEIR ANTI-MICROBIAL ACTIVITY | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (US) | 2012-01-05 | — | — | WO | disclosed |
| EP-1487428-B1 | AMINO-SUBSTITUTED (E)-2,6-DIALKOXYSTYRYL 4-SUBSTITUTED BENZYLSULFONES FOR TREATING PROLIFERATIVE DISORDERS | UNIV TEMPLE (US) | 2011-09-21 | — | — | EP | disclosed |
| WO-2009128805-A1 | ON01910. NA ENHANCES CHEMOTHERAPEUTIC AGENT ACTIVITY IN DRUG-RESISTANT TUMORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-10-22 | — | — | WO | disclosed |
| WO-2008033475-A2 | ACTIVATED CYTOTOXIC COMPOUNDS FOR ATTACHMENT TO TARGETING MOLECULES FOR THE TREATMENT OF MAMMALIAN DISEASE CONDITIONS | ONCONOVA THERAPEUTICS, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| US-20070031964-A1 | Myeloma cell culture in transferrin-free low iron medium | MEDIMMUNE LIMITED (GB) | 2007-02-08 | — | — | US | disclosed |